• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Model Number RRT07070080L
Device Problem Contamination (1120)
Patient Problem Pyogenic Infection (4554)
Event Date 10/21/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It has been reported to gore that, on (b)(6) 2016 the patient underwent an endovascular repair of peripheral arterial disease located in the common femoral artery and was treated with a gore-tex vascular graft, the patient received heparin as an additional antiplatelet treatment.The procedure was uneventful and the patient was discharged on (b)(6) 2016.On (b)(6) 2016 an unplanned open surgery reintervention was performed because of a periprosthetic graft infection and a wound drainage system was constructed.The patency of the device was maintained at the end of the procedure.It was reported that on (b)(6) 2016 an elective open repair surgical reintervention was performed because of an infected vascular graft which was explanted.It was reported that the patency of the gore-tex vascular graft was not restored at the end of the procedure.The patient was discharged on (b)(6) 2016.
 
Manufacturer Narrative
H10/11: code d12: according to the gore tex® vascular grafts instructions for use, complications which may occur in conjunction with the use of any vascular prosthesis include but are not limited to: infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
wilson okeke
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15102362
MDR Text Key296570179
Report Number2017233-2022-03158
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132611034
UDI-Public00733132611034
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K880167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/19/2021
Device Model NumberRRT07070080L
Device Catalogue NumberRRT07070080L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/27/2022
Initial Date FDA Received07/26/2022
Supplement Dates Manufacturer Received11/22/2022
11/22/2022
Supplement Dates FDA Received11/22/2022
12/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/21/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient SexMale
-
-